Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05026866 |
|---|---|
| Brief Title: | A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3) |
| First Submitted : | August 27, 2021 |
| First Submitted that Met QC Criteria : | August 27, 2021 |
| First Posted : | August 30, 2021 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 19, 2024 |